Introduction During steady state conditions, adhesive interactions between the bone marrow (BM) stromal cells and primitive hematopoietic cells mostly result in stem cell retention, in a noncycling and nonmotile mode. However, low levels of progenitor cells are continuously released from the BM to the blood circulation as part of homeostasis. This process is dramatically amplified during emergency situations because of damage and cell death, as part of host defense and repair, in response to stress signals, including cytokines such as granulocyte colony-stimulating factor (G-CSF). Repetitive G-CSF stimulations are commonly used in the clinic, mimicking emergency situations to harvest stem and progenitor cells from the circulation for transplantation protocols 1, 2 . The BM reservoir of immature and maturing leukocytes is dynamic, replenishing the blood with new cells on demand. These dynamic changes are achieved through a complex interplay between the immune and nervous systems, the bones and the BM microenvironment, involving cytokines, chemokines, proteolytic enzymes, and adhesion molecules 3 . In particular, oscillations in BM levels of stromal cell-derived factor 1 (SDF-1; transiently increased and subsequently degraded) and CXC chemokine receptor-4 (CXCR4) activation play a crucial role in promoting progenitor cell egress 4, 5 . The cytokine hepatocyte growth factor (HGF) and its receptor c-Met control complex biologic programs known as "invasive growth" and tumor spreading. 6 Reactive oxygen species (ROS) are constantly generated during intracellular metabolism and in response to cytokines. Although excess ROS can cause oxidative damage to DNA, moderate levels have important roles in cell signaling, regulating different physiologic and pathologic cellular processes, including cell-cycle progression, migration, and invasion.7 Finally, redox signaling has emerged as an important regulator of hematopoietic stem cell (HSC) self-renewal and lifespan 8, 9 . The Forkhead Box, class O (FOXO) family of Forkhead transcription factors is a regulator of oxidative stress 10 . Loss of FOXO function in HSCs results in increased ROS levels, defective maintenance of quiescence, and reduced long-term repopulating ability 11, 12 . FOXOs are a direct substrate of the protein kinase Akt, a mammalian target of rapamycin inhibition (mTOR) target 13 , which inactivates them by phosphorylation 14 .
In this study, we demonstrate that c-Met expression levels on immature and maturing leukocytes in the BM reservoir are dynamic and dramatically increased when urgent requirements for enhanced leukocyte production and recruitment emerge. Moreover, full c-Met activation requires the integrity of SDF-1/CXCR4 signaling pathways. We also show that c-Met activation generates a mTOR/FOXO3a/ROS signaling cascade, which induces quiescent and nonmotile BM hematopoietic progenitor cells to acquire migrating features that are needed for their recruitment as part of host defense and repair mechanisms. The c-Met inhibitor PHA-665752 (a kind gift from Dr James Christensen and Pfizer) was dissolved in 7.5 μL of dimethyl sulfoxide (DMSO) and 400 μL of PBS and delivered as 7.5 mg/kg twice a day intraperitoneally for 5 consecutive days together with G-CSF. DMSO and PBS were delivered as control vehicle. CXCR4 signaling was blocked by intraperitoneal injection of CXCR4 neutralizing Abs (10 μg) on the last 2 days of G-CSF injections 4 . Mice were also mobilized by 2 daily intraperitoneal injections of 4 mg of HGF (R&D Systems). This protocol was chosen as optimal for progenitor cell mobilization in most mice. Mice requiring additional HGF stimulations for mobilization were excluded. The antioxidant N-acetyl-L-cysteine (NAC; Sigma-Aldrich) was administered subcutaneously at 50 mg/kg for 2 days alone or together with G-CSF or HGF. Rapamycin (Rapamune/Sirolimus; Wyeth) was delivered at 480 μg/kg subcutaneously for 2 days. Peripheral blood (PB) from mice asphyxiated with CO 2 was collected by cardiac aspiration in heparinized tubes. White blood cell counts in the circulation were determined by hematocytometer after red blood cell lysis. Unless otherwise indicated, mice were killed 3-5 hours after the last injection.
METHODS

Mice
Colony-forming assay PB mononuclear cells were isolated by Ficoll separation. Total BM cells (1.5 × 10 4 cells/mL) or PB mononuclear cells (2 × 10 5 cells/mL) separated by Ficoll were seeded in semisolid cultures as previously described 4 Colonies were scored 7 days later, according to morphologic criteria.
Lentivirus vector preparation and in vitro cell transduction to silence MET BM cells obtained from mice treated for 5 days with G-CSF were transduced with concentrated lentiviral vectors expressing a c-Met short hairpin RNA (shRNA) or a point-mutated nonfunctional control shRNA 15 . Vector stocks were produced as described previously 16 . The concentration of viral p24 antigen was assessed with the HIV-1 p24 core profile enzyme-linked immunoabsorbent assay (ELISA) kit (NEN Life Science Products) according to the manufacturer's instructions. Cells were transduced overnight in 24-well plates (5 × 10 5 cells/well in 0.5 mL of medium) with the use of 1 mg/mL of p24 equivalents in the presence of 8 mg/mL Polybrene (Sigma-Aldrich) and the following mouse cytokines: stem cell factor (50 ng/mL), thrombopoietin (10 ng/mL), interleukin-6 (10 ng/mL), and fms-like tyrosine kinase-3 ligand (50 ng/mL). Cells transduction was evaluated through green fluorescent protein (GFP) positivity (GFP coding sequence is present in the shRNAcontaining vectors).
Migration assays
Migration assays were performed in Transwell chambers (Costar). The filter upper side was coated with 15 mg/cm 2 reconstituted Matrigel basement membrane (Collaborative Research). Viable cells (10 5 ) previously transduced with c-Met or control shRNAs vectors were seeded in the upper chambers in RPMI 10% fetal bovine serum (FBS), and the lower wells were filled with RPMI 10% fetal bovine serum with SDF-1 (50 ng/mL). After 3 hours, media from the upper and lower wells were collected, and the number of GFP Raw data from reactions that used HGF, FOXO3a, FOXO1, FOXO4, or catalaseprimers were normalized to the corresponding data from reactions that used hypoxantine phosphoribosyltransferase primers. The expression of mMET was analyzed with the use of the Taqman gene-specific probes from Applied Biosystems (Mm00434924_m1, NM_008591) on the total population of BM cells, of which ∼ 50% were positive for GFP expression or on sorted GFP population. In addition, mMET expression was analyzed on sorted GFP + BM cells.
HGF ELISA
To detect HGF protein levels, ELISA Costar strips were coated with 100 μL of goat anti-mouse HGF Ab AF2207 (R&D Systems) at 0.5 μg/mL diluted in PBS and incubated overnight at 4°C. The strips were washed 3 times with wash buffer (0.05% Tween 20 in PBS at pH 7.4) and incubated for 1 hour at room temperature with 300 μL of blocking buffer (1% bovine serum albumin, 5% sucrose, and 0.05% NaN 3 in PBS). After washes, 100 μL of samples undiluted and diluted at 1/2 and 1/10 in a sample diluent (0.1% bovine serum albumin, 0.05% Tween 20 in Tris [tris(hydroxymethyl)aminomethane]-buffered saline at pH 7.3) were loaded, and strips were incubated for 2 hours at room temperature. After washes, 100 μL of biotinylated goat anti-mouse HGF detection Ab BAF2207 (R&D Systems) at 0.4 μg/mL was added, and strips were incubated for 2 hours at room temperature. After washes, 100 μL of 1 μg/mL horseradish peroxidasestreptavidin (Sigma-Aldrich) was added, and strips were incubated for 30 minutes at room temperature. After washes, 100 μL of TMB (3,3′,5,5′-tetramethylbenzidine) substrate solution (Chemicon) was added, and incubation continued for 20-30 minutes. The reaction was stopped by adding 50 μL of 1M H 2 SO 4 solution. Optical density was determined with a microplate reader set at 450 nm. Readings at 570 nm were then subtracted from the results. Recombinant mouse HGF (R&D Systems) was used to generate a linear standard curve.
SDF-1 ELISA
Total protein content in BM fluids was quantified by Bradford assay, and equal protein amounts were assayed for SDF-1 according to previously published protocols 4 . SDF-1 was quantified on BM samples of mice collected after 3-5 hours from the last injection.
c-Met immunoprecipitation
BM cells were lysated with ice-cold RIPA buffer supplemented with fresh 1% protease inhibitors cocktail (Sigma-Aldrich P8340) and 0.2mM per-vanadate as phosphatase inhibitor. Immunoprecipitation was performed according to standard protocols with the use of anti-c-Met Abs B-2 (Santa Cruz Biotechnology). Purified proteins were resolved by 8% sodium dodecylsulfatepolyacrylamide gel electrophoresis under reducing conditions, transferred onto Hybond C nitrocellulose membranes (Whatman GmbH), and immunoblotted with antiphosphotyrosine clone 4G10 (Upstate Biotech) or anti-c-Met (R&D Systems). Final detection was performed with an enhanced chemiluminescence system (Pierce Chemical).
Gelatin zymography
Bones were flushed in PBS, and supernatants were kept on ice. Protein concentration was measured by Bradford protein assay (Bio-Rad Laboratories Inc) Five micrograms of BM proteins were loaded on 10% sodium dodecylsulfate-polyacrylamide gel electrophoresis gels containing 1 mg/mL gelatin. Gels were rinsed for 30 minutes in 2.5% Triton X-100, washed with double-distilled H 2 O, and incubated at 37°C for 16 hours with developing buffer consisting of 50mM Tris (pH 8), 5mM CaCl 2 , 200mM NaCl, and 0.02% Brij (Sigma-Aldrich). Gels were stained with 0.25% Coomassie blue for 3 hours and destained with 5% acetic acid and 10% methanol.
Statistical analysis
Significance levels of data were determined by t test for the differences in mean values.
RESULTS c-Met is up-regulated and activated by G-CSF by SDF-1 signaling
We first investigated the potential roles of HGF and c-Met in a murine model of G-CSF-induced mobilization. Our data show that HGF is accumulated in the blood after 5 consecutive G-CSF injections or even after a single one (which induces progenitor cell release 17 ; Figure 1A ). Moreover, after 5 consecutive injections of G-CSF we observed an increased HGF production in BM leukocytes ( Figure 1B) . Because the most relevant source of HGF is myeloid PMN cells, 18 we examined also HGF production in these cells. Figure 1C shows that HGF levels are increased in PMN cells after 3 days of G-CSF stimulation, peaking at day 5 of G-CSF treatment ( Figure 1C) , correlating with the degree of SKL cell mobilization ( Figure 1D ). Note, exogenous administration of G-CSF to G-CSF −/− mice, which lack granulocytes, 19 failed to mobilize SKL cells ( Figure 1D ) and to promote HGF elevation in the plasma ( Figure 1E . Figure 1H shows that c-Met activation is indeed strongly increased in BM cells after a short incubation with SDF-1 in vitro. Interestingly, we found that SDF-1 stimulation in vitro caused a significant increase in HGF expression on BM leukocytes and, in particular, on BM PMN cells ( Figure 1I ). We then evaluated the effect of CXCR4 neutralization on c-Met activation. CXCR4 neutralization impaired SKL cell mobilization by G-CSF (Figure 1J Table 2 ). Altogether, these results show that c-Met signaling is required for optimal mobilization of stem and progenitor cells during stress-induced conditions.
c-Met signaling regulates SDF-1-induced chemotaxis of progenitor cells
We next investigated whether c-Met was able to directly influence the motility of progenitor cells. We further confirmed the role of c-Met in leukocyte motility by analyzing its effect on the activity of matrix metalloproteinase 9 (MMP-9), a protease involved in enhanced, stress-induced progenitor cell trafficking 23 . Figure 3E shows that, although G-CSF strongly activated MMP-9, the administration of c-Met neutralizing Abs or inhibitor significantly reduced it, indicating its role in MMP-9 activation. Delivery of anti-c-Met Abs or DMSO in steady state did not alter MMP-9 levels ( Figure 3E ).
c-Met regulates ROS production in BM progenitors
Next, we examined the mechanisms underlying c-Met-induced progenitor cell recruitment, focusing on ROS. c-Met silencing in a mouse cell line decreased the production of ROS 24 . A role for ROS in the regulation of HSC-niche interactions 9, 25 and repopulation 8, 11 have been shown.
G-CSF induced a strong increase in ROS production in BM SKL cells, whereas c-Met inhibition substantially impaired it ( Figure 4A ). Moreover, PHA-665752 inhibited G-CSF-induced production of ROS in circulating SKL cells ( Figure 4C ). Consistently, HGF-induced mobilization was accompanied by an increase in ROS production in BM ( Figure 4B ) and circulating SKL cells ( Figure 4C ), indicating a c-Met-dependent generation of ROS.
We next administered to mice the ROS inhibitor NAC Figure 4H,J) . Moreover, it did not alter the BM composition or the number of BM progenitor and SKL cells, and it did not induce apoptosis (supplemental Table 1 ). NAC treatment impaired the enhanced, stress-induced ability of BM leukocytes to migrate toward an SDF-1 gradient in vitro ( Figure 4K ), indicating a role for ROS in promoting cell motility during stress situations.
ROS are generated by c-Met via mTOR-mediated inhibition of FOXO3a
We subsequently investigated how c-Met activation leads to ROS generation in the BM. As shown in Figure 5A , the expression of FOXO3a, a transcriptional factor that mediates resistance to oxidative stress 11, 12 , was down-regulated in the BM after HGF and G-CSF administration. G-CSFinduced decrease of FOXO3a was prevented after treatment with c-Met inhibitor (Figure 5A ). Although G-CSF was able to down-regulate also FOXO1and FOXO4, 2 other members of the FOXO family with a role in the hematopoietic system 11 , c-Met inhibition failed to revert this downregulation ( Figure 5A ). In accordance, no decrease in FOXO1 or FOXO4 was observed after HGF delivery, therefore indicating a selective regulation ofFOXO3a by c-Met signaling in the BM ( Figure  5A ). Of note, the transcription of catalase, a main FOXO3a target 12 , was decreased after HGF or G-CSF treatment but not when c-Met inhibitor was injected together with G-CSF ( Figure 5B ).
To elaborate the signaling cascade, we blocked mTOR signaling by delivering its inhibitor rapamycin 26 . HGF-induced egress of maturing leukocytes ( Figure 5C ), immature progenitor cells ( Figure 5D ), and primitive SKL cells ( Figure 5E-F) was strongly reduced after rapamycin administration. On the contrary, administration of rapamycin in steady state did not alter the egress of mature leukocytes, progenitor cells, or SKL cells ( Figure 5C-F) . Similarly, the numbers of BM progenitor cells or SKL cells were not affected by rapamycin treatment (supplemental Table 1 ). Rapamycin treatment also impaired the HGF-induced decrease in the expression of FOXO3a ( Figure 5G ) and its target gene catalase in the BM ( Figure 5H ). In addition, rapamycin delivery inhibited G-CSF-induced progenitor and SKL cell mobilization 26 . We detected changes in the levels of the inactive phosphorylated FOXO3a levels: rapamycin treatment caused inhibition of the G-CSF-induced increase in the number of BM and PB Lin − /c-kit + /p-FOXO3a + progenitor cells ( Figure 5I and5J, respectively) . All together these findings indicate that c-Met activation induces mTOR signaling, down-regulation of FOXO3a levels, and ultimately increased ROS production.
DISCUSSION
In this study we show an essential role for c-Met in optimal hematopoietic progenitor cell mobilization by regulating their enhanced motility by signaling through the mTOR, FOXO3a, and ROS cascade. Although the involvement of c-Met in cancer progression is well established, not much is known about c-Met functions in normal adult hematopoiesis. Most studies were limited to the analysis of the synergistic effects exerted in vitro by HGF on hematopoietic cell proliferation, in combination with other growth factors [27] [28] [29] [30] . With the use of functional, in vivo mobilization models, we describe a new role for c-Met and its ligand HGF in the regulation of stress induced, accelerated immature and maturing leukocyte recruitment as part of host defense and repair mechanisms. We first show that both the ligand and its receptor are modulated by stress conditions, such as G-CSF-repeated stimulations. Confirming previous studies in mobilized healthy donors 18, 31 , we observed an increase in HGF serum levels in mice receiving G-CSF. Our data also indicate that G-CSF induced an increase in HGF production both in BM leukocytes and PMN cells, the main source for HGF in the hematopoietic compartment 32 . In addition to modulating HGF levels, we show that c-Met expression and activation status are dynamic and are inducible after stress situations such as G-CSF administration. Interestingly, the main regulator of c-Mettranscription, hypoxia inducible factor-1 α, was up-regulated by G-CSF stimulations, correlating progenitor mobilization with an expansion of hypoxic murine BM areas 33 . Thus, the increase in c-Met after G-CSF treatment may be mediated by hypoxia inducible factor-1 α, which also regulates expression of other genes involved in stem cell trafficking such asSDF-1/CXCR4 and vascular endothelial growth factor 34, 35 . Moreover, primitive, quiescent BM HSCs from G-CSF-treated mice have reduced long-term repopulation ability 36 . We show regulation of c-Met activation by SDF-1/CXCR4 signaling. This axis has been extensively reported to be involved in stem cell mobilization. Multiple SDF-1 injections are able to induce osteoclast activation and progenitor cell mobilization 37 ; furthermore, a single dose of SDF-1 is already able to induce progenitor cell release into the circulation 17 . Moreover, neutralizing anti-CXCR4 Abs block progenitor cell mobilization (Petit et al 4 ; Figure 1 ). In support, chimeric mice reconstituted with CXCR4 −/− hematopoietic cells do not mobilize in response to G-CSF 21 .
Our results indicate that G-CSF-induced c-Met activation requires functional CXCR4 signaling because neutralizing CXCR4 Abs that prevent SKL mobilization (Petit et al 4 ; Figure 1J ) also inhibit c-Met activation. Moreover, SDF-1 was able to strongly activate c-Met by up-regulating HGF production in BM leukocytes and PMN cells. The need for CXCR4/SDF-1 signaling for optimal c-Met activation, together with the observation that c-Met is needed for enhanced leukocyte migration to a gradient of SDF-1, suggests mutual interactions between the c-Met and CXCR4 cascades. Interestingly, repeated HGF stimulations were accompanied by a decrease in BM SDF-1 levels, which is mandatory for an optimal progenitor mobilization 4,5 (supplemental Figure 2) . Furthermore, HGF was shown to upregulate CXCR4 expression on immature human CD34 + progenitor cells, 37 ; moreover, our previous study has shown the important role of MT1-MMP in G-CSF-induced mobilization of human and murine progenitor cells. 26 Combining these studies together we can conclude that the HGF/c-Met signaling axis is also involved in activation of MMPs to promote leukocyte recruitment under stress conditions. Our findings provide evidence for cell autonomous effects exerted by c-Met signaling on the enhanced migration of G-CSF-stimulated leukocytes. However, c-Met may regulate progenitor mobilization at multiple levels, not only through a direct effect on BM progenitor cells but also through indirect effects on the BM microenvironment. HGF was reported as an important regulator of the BM microenvironment, controlling osteoclast/osteoblast bone remodeling interactions, which were also shown to promote stem and progenitor cell mobilization. 20, 38 Of note, HGF is also a potent angiogenic factor, 39 and it stimulates production of vascular endothelial growth factor, an important regulator of vascular permeability and leukocyte rolling to the vascular endothelium. 40 Therefore, c-Met might promote progenitor cell mobilization by targeting also the BM vascular niche, an essential location for cell egress. In addition, although motility and proliferation of progenitor cells are regulated by similar factors, c-Met inhibition affected predominantly progenitor cell motility without altering BM progenitor or SKL frequencies. However, it has to be considered that this study focuses on G-CSF-induced mobilization after 5 consecutive G-CSF stimulations. At this time point the cells have already undergone cell proliferation (which occurs at the second and third day of G-CSF treatment), 41 and the predominant phenomena are cell motility and egress. Therefore, although our results indicate that at day 5 of G-CSF stimulation, the frequency of BM SKL is not affected by c-Met inhibition, a role for c-Met in cell proliferation during G-CSF-induced mobilization cannot be ruled out. The analysis of the molecular mechanisms underlying the c-Met role in progenitor cell mobilization pointed out the crucial role of a new, unexpected ROS signaling pathway. We describe a cascade in which c-Met activates the mTOR pathway, which down-regulates FOXO3a expression, thereby leading to ROS production ( Figure 6 ). Notably, blockage of mTOR by rapamycin treatment reduced HGF-induced progenitor cell recruitment, reverted HGF-mediated down-regulation of FOXO3a and of its target gene catalase, in line with a previous study showing that rapamycin targets the activity of mTOR complex 2 (mTORC2). 42 Our data suggest a new role for FOXO3a reduction, which allow increased ROS levels as part of progenitor cell mobilization. In support of our results, a recent finding shows that mice lacking FOXO3adevelop neutrophilia. 43 Of note, rapamycin delivery impaired G-CSF-mediated mobilization, 26 and the phosphatidyl inositol-3 kinase pathway has been described in other systems as an essential player of the c-Met signaling cascade. 44, 45 Moreover, ablation of phosphatase and tensin homologue, a negative regulator of the phosphatidyl inositol-3 kinase /Akt/mTOR pathway, was shown to be associated with reduced BM retention of stem cells.
46,47
Notably, the delivery of the ROS scavenger NAC inhibited G-CSF-and HGF-induced mobilization of mature leukocytes and primitive cells. In support of these results, genetic deficiency of tuberous sclerosis 1, a negative regulator of mTOR, is associated with higher ROS levels. 48 Furthermore, HSCs from AKT1/2 −/− mice, which are stuck in G 0 and have low ROS levels,
show reduced long-term repopulation capacities, 49 suggesting that balanced ROS levels are required for both mobilization and repopulation.
In conclusion, we have shown the dynamic nature of the BM reservoir that induces a dramatic upregulation of c-Met expression and activity, in a CXCR4/SDF-1-dependent manner, to face the rapid and increased demand for leukocytes during stress-induced mobilization. Moreover, we describe a mTOR/FOXO3a/ROS signaling cascade that promotes enhanced progenitor cell recruitment and suggests in vitro NAC treatment to restore long-term repopulation of clinically mobilized stem cells. 
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